Poland – Pharmaceutical products – Sukcesywna dostawa leków i materiałów medycznych dla SPZOZ w Mławie

Poland – Pharmaceutical products – Dostawa produktów leczniczych wykorzystywanych przez oddziały szpitala, leki stosowane w ramach programów lekowych oraz chemioterapii (część 1)

Poland – Pharmaceutical products – Zakup i dostawa leków onkologicznych dla Apteki Szpitalnej Świętokrzyskiego Centrum Onkologii w Kielcach.

Poland – Various medicinal products – Dostawa leków stosowanych w programach lekowych.

Poland – Pharmaceutical products – Zakup i dostawa leków i wyrobów medycznych dla potrzeb Radomskiego Szpitala Specjalistycznego

Poland – Medical equipments – Upgrade rezonansu magnetycznego model Aera 1.5T, numer seryjny 141616 w celu realizacji projektu pn. Rozwój zdolności leczenia onkologicznego w SP ZOZ MSWiA w Lublinie poprzez utworzenie nowych oddziałów wraz z modernizacją bazy sprzętowej

Poland – Fracture appliances, pins and plates – „Dostawa endoprotez i implantów do SP ZOZ Szpitala Wielospecjalistycznego w Jaworznie”

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally

Romania – Diesel fuel – ACHIZITIE MOTORINA STANDARD